Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,491 | -12,878 | -20,062 | -20,703 | -27,326 |
| Depreciation Amortization | 1,563 | 1,641 | 1,936 | 3,299 | 5,902 |
| Accounts receivable | 633 | 926 | 1,375 | -1,248 | -328 |
| Accounts payable and accrued liabilities | -2,573 | 1,457 | -3,998 | -344 | 485 |
| Other Working Capital | -2,001 | 2,296 | -1,940 | -1,852 | -164 |
| Other Operating Activity | 18,926 | -1,728 | 4,736 | 4,154 | 3,695 |
| Operating Cash Flow | $-11,943 | $-8,286 | $-17,953 | $-16,694 | $-17,736 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -85 | -396 | -292 | -911 | -1,826 |
| Net Acquisitions | N/A | N/A | 12,359 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -12 | N/A | -1,003 | -26 |
| Other Investing Activity | 3,390 | -4,465 | 3 | -983 | 197 |
| Investing Cash Flow | $3,305 | $-4,861 | $12,069 | $-1,895 | $-1,629 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 58 | 137 | N/A | N/A | N/A |
| Debt Issued | N/A | 5,664 | N/A | 6,749 | 88 |
| Debt Repayment | -294 | -737 | -7,770 | -711 | -319 |
| Common Stock Issued | 12,509 | 18,015 | N/A | 7,382 | 21,099 |
| Other Financing Activity | -8,313 | 842 | -869 | -175 | -194 |
| Financing Cash Flow | $3,960 | $23,920 | $-8,639 | $13,245 | $20,675 |
| Exchange Rate Effect | 335 | 189 | 25 | -333 | 632 |
| Beginning Cash Position | 14,032 | 2,992 | 17,625 | 22,693 | 21,922 |
| End Cash Position | 9,689 | 13,954 | 3,127 | 17,017 | 23,864 |
| Net Cash Flow | $-4,343 | $10,962 | $-14,497 | $-5,676 | $1,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,943 | -8,286 | -17,953 | -16,694 | -17,736 |
| Capital Expenditure | -268 | -396 | -326 | -911 | -1,826 |
| Free Cash Flow | -12,211 | -8,682 | -18,279 | -17,605 | -19,561 |